Lumida
/COYA
⌘K
Coya Therapeutics Inc

Coya Therapeutics Inc

COYA
$4.38USD-3.10%-0.14 today

MARKET CAP

102.7M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $5

52W RANGE

$4
$8
STATEMENT·Income statement
USD · GAAP
METRICFY 2023FY 2024FY 2025TREND
Sales, Adj.$6.0M$3.6M$7.9M
YoY %-40.8%+123.6%
P / Sales11.8x24.6x12.2x
EV / Sales7.3x15.1x7.2x
Gross Profit, Adj.$6.0M$3.6M$7.9M
YoY %-40.8%+123.6%
Margin %100.0%100.0%100.0%
EV / Gross Profit7.3x15.1x7.2x
EBITDA, Adj.$-7.9M$-17.2M$-22.5M
YoY %+19.5%-118.7%-30.8%
Margin %-131.2%-484.6%-283.5%
EV / EBITDA-5.6x-3.1x-2.5x
EBIT$-7.9M$-17.2M$-22.6M
YoY %+19.5%-118.3%-30.8%
Margin %-131.7%-485.4%-283.9%
EV / EBIT-5.5x-3.1x-2.5x
Net Income$-8.0M$-14.9M$-21.2M
YoY %+34.8%-86.3%-42.6%
Net Margin-133.1%-418.7%-267.1%
EPS (GAAP)-$0.79-$0.98-$1.27
YoY %+83.3%-24.1%-29.6%